中国药物警戒 ›› 2014, Vol. 11 ›› Issue (10): 614-617.

• 药械安全性研究 • 上一篇    下一篇

我国基本药物不良反应监测实践与药品的风险管理

刘翠丽,夏东胜   

  1. 国家食品药品监督管理总局药品评价中心,北京 100045
  • 收稿日期:2014-06-20 修回日期:2016-02-03 出版日期:2014-10-08 发布日期:2016-03-02
  • 作者简介:刘翠丽,女,主管药师,基本药物不良反应监测与评价。

Discussion on the Monitoring of the Adverse Reaction and the Risk Management of Essential Medicines

LIU Cui-li, XIA Dong-sheng   

  1. Center for Drug Reevalutaion,CFDA, Beijing 100045, China)Abastract: Since the implementation of essential medicine system in China, the essential medicine adverse reaction monitoring work has made great achievements.It has been an important guarantee for the smooth implementation of the national essential medicine system. This paper starts from the practice of China's essential medicine monitoring work, analyzes the characteristics of the risk management of essential medicines, in order to cause the colleagues in depth discussion and research on this work, to ensure the safety of the public.
  • Received:2014-06-20 Revised:2016-02-03 Online:2014-10-08 Published:2016-03-02

PDF (PC)

142

摘要： 我国实施基本药物制度以来,基本药物的不良反应监测工作取得了较大成效,其已被作为一项基本手段保障基本药物制度的顺利实施。通过从我国基本药物监测工作的实践着手,剖析基本药物风险管理的特点,以引发同仁对这一工作进行深入研究和探讨,共同保障群众基本用药的安全。

关键词: 基本药物, 不良反应监测, 风险管理

Key words: essential medicines, adverse reaction monitoring, the risk management

中图分类号: